Hepatic encephalopathy due to liver cirrhosis.
Institute of Infection and Global Health, University of Liverpool, Liverpool L69 7BE, UK.
Mark A
MA
Ellul
City Health Centre, Manchester M1 1PL, UK.
Santosh A
SA
Gholkar
Department of Gastroenterology, Royal Liverpool University Hospital, Liverpool L7 8XP, UK tim.cross@rlbuht.nhs.uk.
Timothy J
TJ
Cross
D000418:Albumins / Q000627:therapeutic use; D000596:Amino Acids / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004032:Diet; D004187:Disaccharides / Q000627:therapeutic use; D004351:Drug Resistance; D004569:Electroencephalography; D005990:Glycerol / Q000031:analogs & derivatives / Q000627:therapeutic use; D006501:Hepatic Encephalopathy / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D008279:Magnetic Resonance Imaging; D009355:Neomycin / Q000627:therapeutic use; D009460:Neurologic Examination; D019384:Nucleic Acid Synthesis Inhibitors / Q000627:therapeutic use; D009952:Ornithine / Q000031:analogs & derivatives / Q000627:therapeutic use; D010654:Phenylbutyrates / Q000627:therapeutic use; D019936:Probiotics / Q000627:therapeutic use; D011500:Protein Synthesis Inhibitors / Q000627:therapeutic use; D012294:Rifamycins / Q000627:therapeutic use; D000078262:Rifaximin; D013727:Terminal Care / Q000379:methods; D014057:Tomography, X-Ray Computed
D000418:Albumins; D000596:Amino Acids; D004187:Disaccharides; D019384:Nucleic Acid Synthesis Inhibitors; D010654:Phenylbutyrates; D011500:Protein Synthesis Inhibitors; D012294:Rifamycins; C572232:ornithine phenylacetate; D009952:Ornithine; D009355:Neomycin; D000078262:Rifaximin; D005990:Glycerol; C570223:glycerol phenylbutyrate